The Alzheimer Society of Canada has been made aware of the decision by Biogen Canada Inc. to withdraw its submission of aducanumab from regulatory review by Health Canada as a treatment for people living with early stages of Alzheimer’s disease.
It is with profound sadness and a truly heavy heart that we share the news that dementia researcher and advocate Dr. Karen Kobayashi passed away on May 28, 2022.
Jeff Carney, former President and CEO of IG Wealth Management, was diagnosed with early onset Alzheimer’s in 2020. As a long-time and passionate advocate for people living with Alzheimer’s, Jeff continues to raise awareness and support for those impacted by dementia.
Some TikTok users are exacerbating the stigma around dementia by ridiculing those with memory loss, filming their confusion without their consent.
The Alzheimer Society of Canada was saddened to learn of the recent passing of William Scott Dudgeon, who served as our Chief Executive Officer (CEO) from 2006 to 2009.
Work is underway at the Alzheimer Society of Canada to ensure that dementia knowledge and care are readily accessible for people living with dementia and their carers in culturally diverse communities.
You are not alone. No matter where you live in Canada and what your experience with dementia looks like, we are here to support you. Find out below how to connect to the help you need.
How has the pandemic affected people living with dementia and their family caregivers? Through a new podcast series informed by dementia research, you can hear directly from Canadian families living with dementia, revealing their challenges – and their hopes.